Form 4: BioLife Solutions CHRO Sells Stock for Tax Obligations
Insider Transaction
BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 233 shares of common stock for $26.83 per share to cover tax withholding obligations.
Summary
- Sarah Aebersold, Chief Human Resources Officer of BIOLIFE SOLUTIONS INC (BLFS), reported a sale of common stock.
- The transaction involved the disposition of 233 shares of common stock.
- The shares were sold at a price of $26.83 per share.
- The sale occurred on September 11, 2025.
- The transaction was executed pursuant to a Rule 10b5-1(c) trading plan, which was adopted on March 8, 2024.
- The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock.
- Following this transaction, Sarah Aebersold beneficially owns 78,071 shares of common stock directly.
Sentiment
Score: 5
Explanation: The transaction is a routine, pre-planned sale for tax withholding purposes, which is generally considered neutral and does not reflect a discretionary change in confidence by the insider.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This filing reports a routine insider transaction for tax withholding purposes and does not provide information related to broader industry trends or competitive landscape.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan | The sale was made pursuant to a Rule 10b5-1(c) trading plan adopted on March 8, 2024, which allows insiders to pre-arrange stock transactions to avoid accusations of trading on material non-public information. | 03-08-2024 | This indicates adherence to best practices for insider trading compliance, providing a legal affirmative defense against insider trading allegations for pre-scheduled transactions. |
Stakeholder Impact
- Shareholders: The impact on shareholders is minimal as this is a routine, non-discretionary sale for tax purposes and does not signal a change in management's outlook on the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 03-08-2024 | Date Rule 10b5-1(c) trading plan was adopted by Sarah Aebersold. |
| 09/11/2025 | Date of common stock transaction (sale). |
| 09/15/2025 | Date the Form 4 was signed by Sarah Aebersold. |
Keywords
BIOLIFE SOLUTIONS, BLFS, Form 4, insider transaction, stock sale, Sarah Aebersold, 10b5-1 plan, tax withholding, Chief Human Resources Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.